French-headquartered venture capital firm Seventure Partners plans to unlock a third wave of microbiome innovation funds next year, aiming to invest €300 million in more than 20 cutting-edge companies, its CEO says.
Significant investment is required to get innovative protein start-ups off the ground. So what are investors looking for when deciding to bankroll new talent? And what do they predict for the future of protein? Cargill and S2G Ventures weigh in.